Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

Similar articles for PubMed (Select 12775614)

1.

Pharmaceutical industry sponsorship and research outcome and quality: systematic review.

Lexchin J, Bero LA, Djulbegovic B, Clark O.

BMJ. 2003 May 31;326(7400):1167-70. Review.

2.
3.

Industry sponsorship and research outcome.

Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L.

Cochrane Database Syst Rev. 2012 Dec 12;12:MR000033. doi: 10.1002/14651858.MR000033.pub2. Review.

PMID:
23235689
4.

Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies?

Golder S, Loke YK.

Br J Clin Pharmacol. 2008 Dec;66(6):767-73. doi: 10.1111/j.1365-2125.2008.03272.x. Epub 2008 Jul 31. Review.

5.

Association of industry sponsorship to published outcomes in gastrointestinal clinical research.

Brown A, Kraft D, Schmitz SM, Sharpless V, Martin C, Shah R, Shaheen NJ.

Clin Gastroenterol Hepatol. 2006 Dec;4(12):1445-51. Epub 2006 Nov 13.

PMID:
17101295
6.

The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.

Schott G, Pachl H, Limbach U, Gundert-Remy U, Ludwig WD, Lieb K.

Dtsch Arztebl Int. 2010 Apr;107(16):279-85. doi: 10.3238/arztebl.2010.0279. Epub 2010 Apr 23. Review.

7.

The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication.

Schott G, Pachl H, Limbach U, Gundert-Remy U, Lieb K, Ludwig WD.

Dtsch Arztebl Int. 2010 Apr;107(17):295-301. doi: 10.3238/arztebl.2010.0295. Epub 2010 Apr 30. Review.

8.
9.

Evaluating solutions to sponsorship bias.

Doucet M, Sismondo S.

J Med Ethics. 2008 Aug;34(8):627-30. doi: 10.1136/jme.2007.022467.

PMID:
18667655
10.

Outcome reporting among drug trials registered in ClinicalTrials.gov.

Bourgeois FT, Murthy S, Mandl KD.

Ann Intern Med. 2010 Aug 3;153(3):158-66. doi: 10.7326/0003-4819-153-3-201008030-00006.

11.

[Research in the pharmaceutical industry cannot be objective].

Becker-BrĂ¼ser W.

Z Evid Fortbild Qual Gesundhwes. 2010;104(3):183-9. German.

PMID:
20608245
13.

Relationship between sponsorship and failure rate of dental implants: a systematic approach.

Popelut A, Valet F, Fromentin O, Thomas A, Bouchard P.

PLoS One. 2010 Apr 21;5(4):e10274. doi: 10.1371/journal.pone.0010274.

15.
16.

Implications of pharmaceutical industry funding on clinical research.

Lexchin JR.

Ann Pharmacother. 2005 Jan;39(1):194-7. Epub 2004 Nov 23.

PMID:
15562137
17.

Those who have the gold make the evidence: how the pharmaceutical industry biases the outcomes of clinical trials of medications.

Lexchin J.

Sci Eng Ethics. 2012 Jun;18(2):247-61. doi: 10.1007/s11948-011-9265-3. Epub 2011 Feb 15.

PMID:
21327723
18.

Influence of drug company authorship and sponsorship on drug trial outcomes.

Tungaraza T, Poole R.

Br J Psychiatry. 2007 Jul;191:82-3.

19.

Industry sponsorship and authorship of clinical trials over 20 years.

Buchkowsky SS, Jewesson PJ.

Ann Pharmacother. 2004 Apr;38(4):579-85. Epub 2004 Feb 24. Review.

PMID:
14982982
20.

Prevalence and outcomes of pharmaceutical industry-sponsored clinical trials involving clozapine, risperidone, or olanzapine.

Procyshyn RM, Chau A, Fortin P, Jenkins W.

Can J Psychiatry. 2004 Sep;49(9):601-6. Review.

PMID:
15503731
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk